Cardiology and Cardiac Surgery

Structural Heart Program

The Structural Heart Program at NewYork-Presbyterian Brooklyn Methodist Hospital, in partnership with Weill Cornell Medicine, provides traditional and minimally invasive catheter-based and hybrid surgical procedures for patients with severe aortic stenosis, mitral regurgitation, failing bioprosthetic valves (aortic & mitral) and several other structural heart defects.

The Structual Heart Program’s team of collaborative experts has played a leading role in clinical trials assessing the latest percutaneous valve replacement approaches, giving our Program greater experience than most in these emerging new techniques.

Transcatheter Aortic Valve Replacement

Transcatheter Aortic Valve Replacement (TAVR) is a minimally invasive technique

cardio-tavr-commander-tf-step2
During TAVR, a prosthetic valve is delivered to the heart via a catheter. The prosthetic valve is carefully positioned inside the patient’s own valve and expanded. The diseased leaflets are pushed aside and replaced with the new valve, which will immediately begin to function.
used for the treatment of aortic stenosis. TAVR enables people with aortic stenosis who are unable to have open-heart surgery (due to age or illness) to receive this lifesaving care.

During TAVR, a catheter delivers a prosthetic valve to the heart. The prosthetic valve is carefully positioned inside the patient’s own valve and expanded. The diseased leaflets are pushed aside and replaced with the new valve, which will immediately begin to function.

NewYork-Presbyterian Brooklyn Methodist’s Structural Heart Program has been on the forefront of emerging TAVR technology, performing these procedures since 2014. Our physicians are seasoned in different TAVR approaches, and are able to safely deliver TAVR for patients with unique anatomical or physiological concerns.

Transcatheter Mitral Valve Replacement

A transcatheter mitral valve replacement (TMVR), a highly specialized and minimally invasive technique, may also be offered as an alternative for patients with failing bioprosthetic mitral valves.

MitraClip®

MitraClip®, a catheter-based treatment, will be available for patients with significant symptomatic degenerative mitral regurgitation who are too high-risk for surgery.

This procedure is performed using the Watchman™, or LARIAT® device, in select patients who are at risk for stroke and are unable to tolerate standard anticoagulation therapy.

Paravalvular Leak Closure (Mitral or Aortic)

Our valve specialists repair paravalvular prosthetic regurgitation percutaneously in select high-risk patients who are experiencing symptoms.

cardio-tavr-watchman
A Watchman™ procedure being performed through the Structural Heart Program at NewYork-Presbyterian Brooklyn Methodist Hospital.

ASD Closure (Transcatheter)

An atrial septal defect (ASD) is an abnormal communication between the two upper chambers of the heart. To treat ASD, a special closure device will be inserted into the heart via a catheterization procedure. The patient is discharged to home on the day after procedures, without any limitations of activity.

PFO Closure

A patent foramen ovale (PFO) is a vestigial remnant from the development of the heart prior to birth. Similar to the ASD Closure procedure, a special closure device will be inserted into the heart via a catheterization procedure. The patient is discharged to home on the day after procedure.

Our physicians collaborate with a robust team of clinical specialists across the NewYork-Presbyterian network, who compassionately attend to all patient needs. Our commitment to comprehensive communication within our team, as well as with the patient, their family members and referring physician, ensures everyone stays informed and involved in the patient’s care.

To make an appointment for a consultation, please call the Structural Heart Program at